Diagnosing Acute Promyelocytic Leukemia (APL): The presence of this genetic alteration is a hallmark of this type of leukemia. Assessing Disease Progression: It helps evaluate the severity of the disease and how much it has spread. Monitoring Treatment Response: The test is used to track how well the patient is responding to targeted therapies. Early Diagnosis: It contributes to the early and accurate diagnosis of APL, allowing for timely treatment. Monitoring Treatment Effectiveness: It helps determine if the treatment is effective, especially with therapies like all-trans retinoic acid (ATRA) and arsenic trioxide (ATO).

Patients with Acute Promyelocytic Leukemia (APL): Those showing symptoms that suggest this type of leukemia. Individuals with Unexplained Signs or Symptoms Related to Blood Disorders: For example, easy bruising or excessive bleeding. Patients Previously Diagnosed with Other Blood Disorders: Those who need further evaluation or clarification regarding their condition. Patients Undergoing Chemotherapy or Targeted Therapy for Leukemia: To monitor the response to treatment.

Signs of Leukemia: Such as severe fatigue, unexplained weight loss, fever, and night sweats, which may suggest blood disorders. Bruising and Bleeding: Unexplained bruising or excessive bleeding, such as frequent nosebleeds or gum bleeding, which could indicate platelet problems or the body's response to medications. Changes in Blood Cell Counts: Such as an unexplained decrease in white or red blood cells, which may require further evaluation. Symptoms of Bone Marrow Failure: Such as general weakness, dizziness, or difficulty breathing, which are signs of compromised blood cell production. Family History: A family history of blood cancers or leukemia may prompt this test as part of a comprehensive evaluation.

What is the PML-RAR Alpha test? The PML-RAR Alpha test is used to detect the presence of the PML-RAR Alpha gene, which is associated with certain types of leukemia, such as acute promyelocytic leukemia (APL). How is the test performed? A sample of blood or bone marrow is collected and then sent to a laboratory for analysis. Is any special preparation required before the test? Typically, no special preparation is required for the test. However, it's best to consult with your doctor to confirm. What are the expected results? Positive results indicate the presence of the gene, which would require further testing to confirm the diagnosis. What are the risks associated with the test? The risks are minimal and primarily involve discomfort or bruising at the site where the sample is drawn. What do abnormal results mean? Abnormal results suggest the possibility of blood disorders, and may require additional tests or medical evaluation. How long does it take to get results? Results usually take a few days, but the timeframe can vary depending on the laboratory.

Negative result: Indicates the absence of the gene, suggesting that the specific type of leukemia is not present. Positive result: Indicates the presence of the gene, which requires further testing and medical evaluation to confirm the diagnosis.

PML-RAR Alpha Genetic Test | Lahalak Platform

An advanced genetic test to detect mutations linked to acute promyelocytic leukemia, supporting early diagnosis and rapid therapeutic intervention for optimal health outcomes.

Prices starts from: 1458.66 SAR

Scientific name: PML-RAR Alpha Genetic Test

PML-RAR Alpha analysis is a laboratory test used to detect genetic changes associated with acute promyelocytic leukemia (APL). This test is linked to the presence of the PML-RAR alpha gene, which results from the fusion of two different genes, leading to alterations in cell growth. It is an important tool for diagnosing the disease, helping physici...

Service type Genetic test (Blood)

Duration 10-15 minutes

Fasting Fasting is not required

Prices Starting from 1458.66 SAR

Included Services

PML-RAR Alpha Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

Diagnosing Acute Promyelocytic Leukemia (APL): The presence of this genetic alteration is a hallmark of this type of leukemia.
Assessing Disease Progression: It helps evaluate the severity of the disease and how much it has spread.
Monitoring Treatment Response: The test is used to track how well the patient is responding to targeted therapies.
Early Diagnosis: It contributes to the early and accurate diagnosis of APL, allowing for timely treatment.
Monitoring Treatment Effectiveness: It helps determine if the treatment is effective, especially with therapies like all-trans retinoic acid (ATRA) and arsenic trioxide (ATO).

Recommended groups

Patients with Acute Promyelocytic Leukemia (APL): Those showing symptoms that suggest this type of leukemia.
Individuals with Unexplained Signs or Symptoms Related to Blood Disorders: For example, easy bruising or excessive bleeding.
Patients Previously Diagnosed with Other Blood Disorders: Those who need further evaluation or clarification regarding their condition.
Patients Undergoing Chemotherapy or Targeted Therapy for Leukemia: To monitor the response to treatment.

Symptoms indicative

Signs of Leukemia: Such as severe fatigue, unexplained weight loss, fever, and night sweats, which may suggest blood disorders.
Bruising and Bleeding: Unexplained bruising or excessive bleeding, such as frequent nosebleeds or gum bleeding, which could indicate platelet problems or the body's response to medications.
Changes in Blood Cell Counts: Such as an unexplained decrease in white or red blood cells, which may require further evaluation.
Symptoms of Bone Marrow Failure: Such as general weakness, dizziness, or difficulty breathing, which are signs of compromised blood cell production.
Family History: A family history of blood cancers or leukemia may prompt this test as part of a comprehensive evaluation.

FAQs

What is the PML-RAR Alpha test? The PML-RAR Alpha test is used to detect the presence of the PML-RAR Alpha gene, which is associated with certain types of leukemia, such as acute promyelocytic leukemia (APL).
How is the test performed? A sample of blood or bone marrow is collected and then sent to a laboratory for analysis.
Is any special preparation required before the test? Typically, no special preparation is required for the test. However, it's best to consult with your doctor to confirm.
What are the expected results? Positive results indicate the presence of the gene, which would require further testing to confirm the diagnosis.
What are the risks associated with the test? The risks are minimal and primarily involve discomfort or bruising at the site where the sample is drawn.
What do abnormal results mean? Abnormal results suggest the possibility of blood disorders, and may require additional tests or medical evaluation.

Normal Levels

Negative result: Indicates the absence of the gene, suggesting that the specific type of leukemia is not present.
Positive result: Indicates the presence of the gene, which requires further testing and medical evaluation to confirm the diagnosis.

Conditions & Notices

The terms and conditions announced on the "Lahalak" medical platform apply.
There are no special conditions for the service other than those mentioned.

PML-RAR Alpha Genetic Test | Lahalak Platform

Included Services

Medical Service Information

Purpose Test

Recommended groups

Symptoms indicative

FAQs

Normal Levels

Conditions & Notices

Medical services you might also like

Organic Acids Balance

Fatty Acid Disorders Profile

Leukemia Gene Fusion Test

Factor V Hong Kong Mutation Test